Regulatory Affairs Archives

Partnership with Greenleaf Enhances Strategic Regulatory Affairs Capabilities

February 2, 2021

“This partnership strengthens our global Regulatory Affairs offering and allows us to expand our strategic capabilities to support our Sponsors’ programs.” – Jon Isaacsohn, MD, FACC, Executive Vice President at Medpace.

Conducting Clinical Research in Argentina

Clinical Development

Shortened Timelines for Regulatory Review by ANMAT Make Argentina an Excellent Choice for Clinical Research

July 27, 2017

Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace

On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation that significantly reduces the timelines for the approval of clinical trials. In this post, I discuss the key changes and the advantages this offers Sponsors who are looking to conduct clinical trials in Latin America.